Add like
Add dislike
Add to saved papers

Integration of Soybean ( Glycine max ) Resistance Levels to Sclerotinia Stem Rot into Predictive Sclerotinia sclerotiorum Apothecial Models.

Plant Disease 2023 Februrary 2
Sclerotinia stem rot (SSR) is a major disease of soybean across the Upper Midwest region of the United States. Management of this disease has relied on fungicide applications, yet due to the environmental conditions necessary for SSR to develop, many of these applications are unnecessary. To mitigate this, predictive models have been developed using localized weather data for predicting the formation of S. sclerotiorum apothecia, the inoculum source of SSR, and these models were integrated into a decision support system called Sporecaster©. However, these models do not account for the soybean resistance levels to SSR. In this study, fungicide trials were performed across seven site-years in Wisconsin between 2020-2022 examining fungicide applications applied at one of three action thresholds (low, moderate, and high) following Sporecaster© recommendations in combination with four soybean varieties representing three SSR resistance levels (susceptible, moderately resistant, and resistant). From these trials, the low and moderate action thresholds resulted in similarly low DIX levels comparable to the standard across all varieties. However, the low action threshold was most accurate for predicting SSR development in the susceptible variety, and the high action threshold was most accurate for predicting SSR development for the three resistant varieties. Both the susceptible soybean and a moderately-resistant line yielded similarly high. Additionally, the use of all fungicide applications led to similar partial profits at grain sale prices of either $0.44 kg-1 or $0.55 kg-1 . Overall, this study uncovered relationships between soybean resistance levels to SSR and Sporecaster©, allowing for improved recommendations for fungicide applications.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app